Carla Damaschin

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

University Hospital Cologne(Current)

Charité - Universitätsmedizin Berlin

Paracelsus Medical University

University Hospital Ulm

Integrated Oncology (United States)

Carla Damaschin is an author at University Hospital Cologne specializing in oncology, hematologic malignancy pharmacotherapy, and combination chemotherapy.

Publications per year

2021–2025

Publications

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

Carla Damaschin, Helen Goergen, Stefanie Kreissl et al. · Leukemia · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial

Justin Ferdinandus, Horst Müller, Carla Damaschin et al. · Annals of Oncology · 2023 · 10 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16

Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial

Justin Ferdinandus, Gundolf Schneider, Alden A. Moccia et al. · The Lancet Oncology · 2025 · 10 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

1–3 of 3